Relay Therapeutics
RLAY
RLAY
148 hedge funds and large institutions have $2.02B invested in Relay Therapeutics in 2022 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 69 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
+8
Holders Change %
+5.71%
% of All Funds
2.5%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.08%
New
25
Increased
69
Reduced
23
Closed
14
Calls
$5.88M
Puts
–
Net Calls
+$5.88M
Net Calls Change
+$5.68M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$27.9M |
| 2 |
State Street
Boston,
Massachusetts
|
+$25.5M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$24M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.8M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$13.7M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$48.7M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$16M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$2.44M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$2.33M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.19M |
